Chemed Corp (NYSE:CHE)
$ 575.24 1.11 (0.19%) Market Cap: 8.68 Bil Enterprise Value: 8.51 Bil PE Ratio: 30.96 PB Ratio: 7.33 GF Score: 96/100

Chemed Corp at Credit Suisse Healthcare Conference (Virtual) Transcript

Nov 10, 2020 / 05:30PM GMT
Release Date Price: $477.33 (-0.18%)
David P. Williams
Chemed Corporation - Executive VP & CFO

This is Chemed. We're here.

Albert J. William Rice;dit Suisse AG
CrÃ;Research Division - Research Analyst

© -

Yes. Hi, everyone. It's A.J. Rice, the health care service analyst at Credit Suisse. We're very happy to have next up speaking is Chemed Corporation.

We're joined today by Kevin McNamara, President and Chief Executive Officer; Dave Williams, Executive Vice President and Chief Financial Officer; and Nick Westfall, Chief Financial Officer of VITAS.

Nicholas Michael Westfall
VITAS Healthcare Corporation - CEO & President

CEO.

Albert J. William Rice;dit Suisse AG;David P.
CrÃ;Research Division - Research Analyst

© -

Oh, CEO, I'm sorry, VITAS. Sorry about that. Let me maybe pass it on to David to make a few comments, introductory sort of level set people that may be new to the Chemed story. And then we'll have some Q&A.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot